CureVac N.V. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.56 | $0.02 | -$0.27 |
| Q2 2024 | 1 | -$0.58 | $0.02 | -$0.28 |
| Q3 2024 | 1 | $1.40 | $1.41 | $1.41 |
| Q4 2024 | 2 | -$0.52 | $0.05 | -$0.24 |
| Q1 2025 | 1 | -$0.32 | $0.01 | -$0.16 |
| Q2 2025 | 1 | -$0.27 | $0.01 | -$0.13 |
| Q3 2025 | 1 | -$0.24 | $0.01 | -$0.11 |
| Q4 2025 | 1 | -$0.21 | $0.01 | -$0.10 |
CureVac N.V. Earnings Date And Information
CureVac N.V. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $1.65 earnings per share for the quarter, topping analysts' consensus estimates of $0.67 by $0.98. The company had revenue of 493.90 M for the quarter and had revenue of 53.76 M for the year. CureVac N.V. has generated $-1 earnings per share over the last year ($-1.18 diluted earnings per share) and currently has a price-to-earnings ratio of 5.18. CureVac N.V. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 23rd, 2025 based on prior year's report dates.
CureVac N.V. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | $0.67 | $0.00 | $3.34 M | $493.90 M | |
| 08/15/2024 | Q2 2024 | -$0.26 | -$0.32 | -0.06 | $8.02 M | $14.44 M |
| 05/23/2024 | Q1 2024 | -$0.31 | $12.37 M | |||
| 04/24/2024 | Q4 2023 | -$0.38 | $21.99 M | |||
| 11/14/2023 | Q3 2023 | -$0.26 | -$0.22 | 0.04 | $17.02 M | $16.48 M |
| 08/17/2023 | Q2 2023 | -$0.30 | $20.62 M | $7.58 M | ||
| 05/30/2023 | Q1 2023 | -$0.29 | -$0.27 | 0.02 | $7.13 M | |
| 04/25/2023 | Q4 2022 | -$0.31 | -$0.66 | -0.35 | $11.69 M | |
| 11/17/2022 | Q3 2022 | -$0.26 | $20.40 M | $11.21 M | ||
| 05/25/2022 | Q2 2022 | -$0.31 | $17.86 M | $20.15 M | ||
| 05/25/2022 | Q1 2022 | -$0.08 | $24.37 M | |||
| 04/28/2022 | Q4 2021 | -$0.57 | -$0.01 | 0.56 | $41.23 M | |
| 12/17/2021 | Q3 2021 | -$0.80 | $23.47 M | $29.34 M | ||
| 12/17/2021 | Q2 2021 | -$0.84 | $12.34 M | $22.40 M | ||
| 03/30/2021 | Q1 2021 | -$0.62 | $10.03 M | |||
| 04/27/2021 | Q4 2020 | -$0.32 | $6.00 M | |||
| 09/29/2020 | Q3 2020 | -$0.20 | $53.06 M | $5.16 M | ||
| 06/29/2020 | Q2 2020 | -$0.06 | $34.55 M | |||
| 03/30/2020 | Q1 2020 | -$0.14 | $3.12 M | |||
| 12/30/2019 | Q4 2019 | -$0.20 | $6.82 M |
CureVac N.V. Earnings: Frequently Asked Questions
-
When is CureVac N.V.'s earnings date?
CureVac N.V. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 23rd, 2025 based off last year's report dates.
-
Did CureVac N.V. beat their earnings estimates last quarter?
In the previous quarter, CureVac N.V. (:CVAC) reported $1.65 earnings per share (EPS) to beat the analysts' consensus estimate of $0.67 by $0.98.
-
How can I listen to CureVac N.V.'s earnings conference call?
The conference call for CureVac N.V.'s latest earnings report can be listened to online.
-
How can I read CureVac N.V.'s conference call transcript?
The conference call transcript for CureVac N.V.'s latest earnings report can be read online.
-
How much revenue does CureVac N.V. generate each year?
CureVac N.V. (:CVAC) has a recorded annual revenue of $53.76 M.
-
How much profit does CureVac N.V. generate each year?
CureVac N.V. (:CVAC) has a recorded net income of $53.76 M. CureVac N.V. has generated $-1.18 earnings per share over the last four quarters.
-
What is CureVac N.V.'s price-to-earnings ratio?
CureVac N.V. (:CVAC) has a price-to-earnings ratio of 5.18 and price/earnings-to-growth ratio is 0.28.
